154 related articles for article (PubMed ID: 36255643)
1. Expression and Crystallization of HDAC6 Tandem Catalytic Domains.
Langousis G; Sanchez J; Kempf G; Matthias P
Methods Mol Biol; 2023; 2589():467-480. PubMed ID: 36255643
[TBL] [Abstract][Full Text] [Related]
2. Immunoprecipitation of HDAC6 and Interacting Proteins.
Wang L; Sanchez J; Hess D; Matthias P
Methods Mol Biol; 2023; 2589():493-508. PubMed ID: 36255645
[TBL] [Abstract][Full Text] [Related]
3. Methods for the expression, purification, and crystallization of histone deacetylase 6-inhibitor complexes.
Osko JD; Christianson DW
Methods Enzymol; 2019; 626():447-474. PubMed ID: 31606087
[TBL] [Abstract][Full Text] [Related]
4. Binding of inhibitors to active-site mutants of CD1, the enigmatic catalytic domain of histone deacetylase 6.
Osko JD; Christianson DW
Acta Crystallogr F Struct Biol Commun; 2020 Sep; 76(Pt 9):428-437. PubMed ID: 32880591
[TBL] [Abstract][Full Text] [Related]
5. Structural insights into HDAC6 tubulin deacetylation and its selective inhibition.
Miyake Y; Keusch JJ; Wang L; Saito M; Hess D; Wang X; Melancon BJ; Helquist P; Gut H; Matthias P
Nat Chem Biol; 2016 Sep; 12(9):748-54. PubMed ID: 27454931
[TBL] [Abstract][Full Text] [Related]
6. Fluorescence Polarization-Based Competition Assays to Evaluate Histone Deacetylase 6 Inhibitors.
Ashraf QF; Quilates EJ; Olaoye OO; de Araujo ED; Gunning PT
Methods Mol Biol; 2023; 2589():481-492. PubMed ID: 36255644
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and Biological Investigation of Phenothiazine-Based Benzhydroxamic Acids as Selective Histone Deacetylase 6 Inhibitors.
Vögerl K; Ong N; Senger J; Herp D; Schmidtkunz K; Marek M; Müller M; Bartel K; Shaik TB; Porter NJ; Robaa D; Christianson DW; Romier C; Sippl W; Jung M; Bracher F
J Med Chem; 2019 Feb; 62(3):1138-1166. PubMed ID: 30645113
[TBL] [Abstract][Full Text] [Related]
8. Identification and Structure-Activity Relationship of HDAC6 Zinc-Finger Ubiquitin Binding Domain Inhibitors.
Ferreira de Freitas R; Harding RJ; Franzoni I; Ravichandran M; Mann MK; Ouyang H; Lautens M; Santhakumar V; Arrowsmith CH; Schapira M
J Med Chem; 2018 May; 61(10):4517-4527. PubMed ID: 29741882
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of HDAC6 increases acetylation of peroxiredoxin1/2 and ameliorates 6-OHDA induced dopaminergic injury.
Jian W; Wei X; Chen L; Wang Z; Sun Y; Zhu S; Lou H; Yan S; Li X; Zhou J; Zhang B
Neurosci Lett; 2017 Sep; 658():114-120. PubMed ID: 28823893
[TBL] [Abstract][Full Text] [Related]
10. Posttranslational modification and beyond: interplay between histone deacetylase 6 and heat-shock protein 90.
Liu P; Xiao J; Wang Y; Song X; Huang L; Ren Z; Kitazato K; Wang Y
Mol Med; 2021 Sep; 27(1):110. PubMed ID: 34530730
[TBL] [Abstract][Full Text] [Related]
11. Unique Molecular Interaction with the Histone Deacetylase 6 Catalytic Tunnel: Crystallographic and Biological Characterization of a Model Chemotype.
Olaoye OO; Watson PR; Nawar N; Geletu M; Sedighi A; Bukhari S; Raouf YS; Manaswiyoungkul P; Erdogan F; Abdeldayem A; Cabral AD; Hassan MM; Toutah K; Shouksmith AE; Gawel JM; Israelian J; Radu TB; Kachhiyapatel N; de Araujo ED; Christianson DW; Gunning PT
J Med Chem; 2021 Mar; 64(5):2691-2704. PubMed ID: 33576627
[TBL] [Abstract][Full Text] [Related]
12. Discovery and Characterization of a Chemical Probe Targeting the Zinc-Finger Ubiquitin-Binding Domain of HDAC6.
Harding RJ; Franzoni I; Mann MK; Szewczyk MM; Mirabi B; Ferreira de Freitas R; Owens DDG; Ackloo S; Scheremetjew A; Juarez-Ornelas KA; Sanichar R; Baker RJ; Dank C; Brown PJ; Barsyte-Lovejoy D; Santhakumar V; Schapira M; Lautens M; Arrowsmith CH
J Med Chem; 2023 Aug; 66(15):10273-10288. PubMed ID: 37499118
[TBL] [Abstract][Full Text] [Related]
13. The disordered N-terminus of HDAC6 is a microtubule-binding domain critical for efficient tubulin deacetylation.
Ustinova K; Novakova Z; Saito M; Meleshin M; Mikesova J; Kutil Z; Baranova P; Havlinova B; Schutkowski M; Matthias P; Barinka C
J Biol Chem; 2020 Feb; 295(9):2614-2628. PubMed ID: 31953325
[TBL] [Abstract][Full Text] [Related]
14. Small Molecule Antagonists of the Interaction between the Histone Deacetylase 6 Zinc-Finger Domain and Ubiquitin.
Harding RJ; Ferreira de Freitas R; Collins P; Franzoni I; Ravichandran M; Ouyang H; Juarez-Ornelas KA; Lautens M; Schapira M; von Delft F; Santhakumar V; Arrowsmith CH
J Med Chem; 2017 Nov; 60(21):9090-9096. PubMed ID: 29019676
[TBL] [Abstract][Full Text] [Related]
15. Unusual zinc-binding mode of HDAC6-selective hydroxamate inhibitors.
Porter NJ; Mahendran A; Breslow R; Christianson DW
Proc Natl Acad Sci U S A; 2017 Dec; 114(51):13459-13464. PubMed ID: 29203661
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in the discovery of potent and selective HDAC6 inhibitors.
Wang XX; Wan RZ; Liu ZP
Eur J Med Chem; 2018 Jan; 143():1406-1418. PubMed ID: 29133060
[TBL] [Abstract][Full Text] [Related]
17. Structural Basis of Catalysis and Inhibition of HDAC6 CD1, the Enigmatic Catalytic Domain of Histone Deacetylase 6.
Osko JD; Christianson DW
Biochemistry; 2019 Dec; 58(49):4912-4924. PubMed ID: 31755702
[TBL] [Abstract][Full Text] [Related]
18. Lysine Deacetylation by HDAC6 Regulates the Kinase Activity of AKT in Human Neural Progenitor Cells.
Iaconelli J; Lalonde J; Watmuff B; Liu B; Mazitschek R; Haggarty SJ; Karmacharya R
ACS Chem Biol; 2017 Aug; 12(8):2139-2148. PubMed ID: 28628306
[TBL] [Abstract][Full Text] [Related]
19. Modulation of histone deacetylase 6 (HDAC6) nuclear import and tubulin deacetylase activity through acetylation.
Liu Y; Peng L; Seto E; Huang S; Qiu Y
J Biol Chem; 2012 Aug; 287(34):29168-74. PubMed ID: 22778253
[TBL] [Abstract][Full Text] [Related]
20. Restoration of mutant hERG stability by inhibition of HDAC6.
Li P; Kurata Y; Endang M; Ninomiya H; Higaki K; Taufiq F; Morikawa K; Shirayoshi Y; Horie M; Hisatome I
J Mol Cell Cardiol; 2018 Feb; 115():158-169. PubMed ID: 29355491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
